Cargando…
Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases
BACKGROUND: The incidence of gastric cancer with liver metastases (GCLM) is 9.9–18.7%, with a median survival time of 11 months and a 5-year survival rate <20%. Multidisciplinary treatment (MDT) is gradually gaining recognition as the most important method. However, specific treatment plans remai...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036491/ https://www.ncbi.nlm.nih.gov/pubmed/32127925 http://dx.doi.org/10.1177/1758835920904803 |